CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 1 of 1
Non-Antibody Products
Page 1,047 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Rebeccamycin | An indolocarbazole antibiotic produced by S. aerocolonigenes ATCC39243 tha… | 2.5 mg | 17914-25 | More Info |
| Rebeccamycin | An indolocarbazole antibiotic produced by S. aerocolonigenes ATCC39243 tha… | 500 µg | 17914-500 | More Info |
| Reboxetine (mesylate) | A selective norepinephrine reuptake inhibitor (IC50s = 8.2 nM) that displa… | 10 mg | 15038-10 | More Info |
| Reboxetine (mesylate) | A selective norepinephrine reuptake inhibitor (IC50s = 8.2 nM) that displa… | 25 mg | 15038-25 | More Info |
| Reboxetine (mesylate) | A selective norepinephrine reuptake inhibitor (IC50s = 8.2 nM) that displa… | 5 mg | 15038-5 | More Info |
| Reboxetine (mesylate) | A selective norepinephrine reuptake inhibitor (IC50s = 8.2 nM) that displa… | 50 mg | 15038-50 | More Info |
| Rec 15/2615 (hydrochloride) | An α1B-AR antagonist (Ki = 0.45 nM for the recombinant human recepto… | 1 mg | 27677-1 | More Info |
| Rec 15/2615 (hydrochloride) | An α1B-AR antagonist (Ki = 0.45 nM for the recombinant human recepto… | 10 mg | 27677-10 | More Info |
| Rec 15/2615 (hydrochloride) | An α1B-AR antagonist (Ki = 0.45 nM for the recombinant human recepto… | 25 mg | 27677-25 | More Info |
| Rec 15/2615 (hydrochloride) | An α1B-AR antagonist (Ki = 0.45 nM for the recombinant human recepto… | 5 mg | 27677-5 | More Info |
| Recombinant Antibody Production | With a long-standing history of antibody production and making high-qualit… | n/a | n/a | More Info |
| Recombinant Prokaryotic Lectin-αGal (P. aeruginosa) | Source: Recombinant His-tagged P. aeruginosa RPL-αGal expressed in E… | 2 mg | 35781-2 | More Info |
| Recombinant Prokaryotic Lectin-αMan (P. aeruginosa) | Source: Recombinant His-tagged P. aeruginosa RPL-αMan expressed in E… | 2 mg | 36395-2 | More Info |
| Recombinant Prokaryotic Lectin-Fuc1 (A. fumigatus) | Source: Recombinant His-tagged A. fumigatus RPL-Fuc1 expressed in E. coli… | 2 mg | 36388-2 | More Info |
| Recombinant Prokaryotic Lectin-Gal1 (P. aeruginosa) | Source: Recombinant His-tagged P. aeruginosa RPL-Gal1 expressed in E. coli… | 2 mg | 36391-2 | More Info |
| Recombinant Prokaryotic Lectin-Gal2 (P. aeruginosa) | Source: Recombinant His-tagged P. aeruginosa RPL-Gal2 expressed in E. coli… | 2 mg | 36392-2 | More Info |
| Recombinant Prokaryotic Lectin-Gal4 (P. asymbiotica) | Source: Recombinant His-tagged P. asymbiotica RPL-Gal4 expressed in E. col… | 2 mg | 36394-2 | More Info |
| Recombinant Prokaryotic Lectin-Gal3 (P. luminescens) | Source: Recombinant His-tagged P. luminescens RPL-Gal3 expressed in E. col… | 2 mg | 36393-2 | More Info |
| Recombinant Prokaryotic Lectin-Man2 (B. cenocepacia) | Source: Recombinant His-tagged B. cenocepacia RPL-Man2 expressed in E. col… | 2 mg | 35585-2 | More Info |
| Recombinant Prokaryotic Lectin-Sia3 | Source: Recombinant His-tagged rotavirus RPL-Sia3 expressed in E. coli &bu… | 2 mg | 36396-2 | More Info |
| Recombinant Prokaryotic Lectin-Sia1 (S. gordonii) | Source: Recombinant His-tagged S. gordonii RPL-Sia1 expressed in E. coli &… | 2 mg | 35782-2 | More Info |
| Recombinant Prokaryotic Lectin-Sia2 (S. gordonii) | Source: Recombinant His-tagged S. gordonii RPL-Sia2 expressed in E. coli &… | 2 mg | 35783-2 | More Info |
| RECTAS | A pre-mRNA splicing modulator; corrects aberrant splicing in a SPREADD usi… | 10 mg | 38322-10 | More Info |
| RECTAS | A pre-mRNA splicing modulator; corrects aberrant splicing in a SPREADD usi… | 50 mg | 38322-50 | More Info |
| Reduced Haloperidol | An active metabolite of haloperidol; formed via reduction of haloperidol b… | 10 mg | 28017-10 | More Info |
| Reduced Haloperidol | An active metabolite of haloperidol; formed via reduction of haloperidol b… | 25 mg | 28017-25 | More Info |
| Reduced Haloperidol | An active metabolite of haloperidol; formed via reduction of haloperidol b… | 5 mg | 28017-5 | More Info |
| Reduced Haloperidol | An active metabolite of haloperidol; formed via reduction of haloperidol b… | 50 mg | 28017-50 | More Info |
| Refametinib | An allosteric, selective inhibitor of MEK1 and MEK2 (IC50s = 19 and 47 nM,… | 1 mg | 16997-1 | More Info |
| Refametinib | An allosteric, selective inhibitor of MEK1 and MEK2 (IC50s = 19 and 47 nM,… | 10 mg | 16997-10 | More Info |
| Refametinib | An allosteric, selective inhibitor of MEK1 and MEK2 (IC50s = 19 and 47 nM,… | 5 mg | 16997-5 | More Info |
| Refametinib | An allosteric, selective inhibitor of MEK1 and MEK2 (IC50s = 19 and 47 nM,… | 50 mg | 16997-50 | More Info |
| Regadenoson | A selective, short-acting adenosine A2A receptor agonist (Ki = 1.1 nM for… | 1 mg | 18814-1 | More Info |
| Regadenoson | A selective, short-acting adenosine A2A receptor agonist (Ki = 1.1 nM for… | 10 mg | 18814-10 | More Info |
| Regadenoson | A selective, short-acting adenosine A2A receptor agonist (Ki = 1.1 nM for… | 25 mg | 18814-25 | More Info |
| Regadenoson | A selective, short-acting adenosine A2A receptor agonist (Ki = 1.1 nM for… | 5 mg | 18814-5 | More Info |
| Regorafenib | A multi-kinase inhibitor; inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and… | 10 mg | 18498-10 | More Info |
| Regorafenib | A multi-kinase inhibitor; inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and… | 25 mg | 18498-25 | More Info |
| Regorafenib | A multi-kinase inhibitor; inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and… | 5 mg | 18498-5 | More Info |
| Regorafenib | A multi-kinase inhibitor; inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and… | 50 mg | 18498-50 | More Info |
| Regorafenib-13C-d3 | An internal standard for the quantification of regorafenib by GC- or LC-MS | 1 mg | 25486-1 | More Info |
| Regorafenib-13C-d3 | An internal standard for the quantification of regorafenib by GC- or LC-MS | 500 µg | 25486-500 | More Info |
| Regorafenib N-oxide | An active metabolite of regorafenib; formed from regorafenib by CYP3A4; in… | 1 mg | 35101-1 | More Info |
| Regorafenib N-oxide | An active metabolite of regorafenib; formed from regorafenib by CYP3A4; in… | 10 mg | 35101-10 | More Info |
| Regorafenib N-oxide | An active metabolite of regorafenib; formed from regorafenib by CYP3A4; in… | 25 mg | 35101-25 | More Info |
| Regorafenib N-oxide | An active metabolite of regorafenib; formed from regorafenib by CYP3A4; in… | 5 mg | 35101-5 | More Info |
| Rehmannioside D | An iridoid glycoside | 1 mg | 29034-1 | More Info |
| Rehmannioside D | An iridoid glycoside | 10 mg | 29034-10 | More Info |
| Rehmannioside D | An iridoid glycoside | 25 mg | 29034-25 | More Info |
| Rehmannioside D | An iridoid glycoside | 5 mg | 29034-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile